Skip to main content


Appropriate Care Guide

Initiating basal insulin in type 2 diabetes mellitus Published on 20 November 2017

This Appropriate Care Guide (ACG) continues from the ACG on oral glucose-lowering agents in type 2 diabetes mellitus (T2DM) and highlights the importance of not delaying insulin therapy. It provides clinicians with a practical guide on initiating basal insulin in T2DM and how to prevent and manage hypoglycaemia.

Download the PDF below to access the full ACG.

Key Messages
1. Start insulin therapy if glycaemic goals are not met on oral glucose-lowering agents alone.
2. Initiate with basal insulin, such as intermediate- or long-acting insulin.
3. When initiating insulin, review concomitant oral glucose-lowering agents. Continue metformin +/- SGLT-2 inhibitors where appropriate.
4. Educate patients and their caregivers about taking preventative measures for hypoglycaemia.

Get Acrobat Readeropens in a new window

Related Links

Appropriate Care Guide   Oral glucose-lowering agents in T2DM

Technology Guidance - Drug   Insulin glargine biosimilar (Basaglar) for the treatment of T1DM and T2DM

Back to Top